Cartalax

Cartalax, also known as CTGF (Connective Tissue Growth Factor), is a synthetic peptide that originates from the C-terminal region of human connective tissue growth factor. This 38-kDa cysteine-rich protein is instrumental in extracellular matrix synthesis, cell adhesion, and tissue repair. The sequence targets the heparin-binding domain of CTGF, making it a valuable resource for research into fibroblast proliferation, collagen deposition, and angiogenesis, contributing to studies on connective tissue mechanisms and regenerative processes.

Free Shipping on orders over $200

Cartalax (also known as CTGF or Connective Tissue Growth Factor) is a synthetic peptide derived from the C-terminal region of human connective tissue growth factor, a 38-kDa cysteine-rich protein involved in extracellular matrix synthesis, cell adhesion, and tissue repair. The peptide sequence corresponds to the heparin-binding domain of CTGF, which has been shown to stimulate fibroblast proliferation, collagen deposition, and angiogenesis in vitro and in animal studies. Cartalax has been researched for its potential to promote wound healing, reduce scar formation, and improve skin texture and elasticity. The peptide’s ability to stimulate extracellular matrix remodeling and cell migration makes it a promising tool for investigating connective tissue repair mechanisms and regenerative medicine applications.

Research Applications

  • Connective Tissue Regeneration: Investigation of Cartalax’s effects on fibroblast function, collagen synthesis, and extracellular matrix remodeling [1]
  • Wound Healing and Scar Formation: Examination of the peptide’s impact on skin repair processes and scar tissue development [2]
  • Angiogenesis Modulation: Study of Cartalax’s influence on endothelial cell migration and blood vessel formation in tissue repair models [3]
  • Regenerative Medicine: Exploration of Cartalax’s potential applications in tissue engineering and biomaterial scaffold integration [1]

Reference Citations

  1. PMC3971543 | https://pmc.ncbi.nlm.nih.gov/articles/PMC3971543/
  2. Wang X et al. (2011) – Wound Repair Regen | https://pubmed.ncbi.nlm.nih.gov/21564548/
  3. Hall-Glenn F et al. (2013) – Cell Mol Life Sci | https://pubmed.ncbi.nlm.nih.gov/22992904/

Important Regulatory Notice

These products are for research use only and are not intended for human consumption, therapeutic use, or diagnostic purposes. All compounds described herein have not been approved by the FDA for human use. These products are strictly intended for in vitro laboratory research and analytical purposes when conducted by qualified research professionals in licensed facilities. Users are responsible for ensuring compliance with all applicable laws regarding purchase and use of these materials.

Important Regulatory Notice

These products are for research use only and are not intended for human consumption, therapeutic use, or diagnostic purposes. All compounds described herein have not been approved by the FDA for human use. These products are strictly intended for in vitro laboratory research and analytical purposes when conducted by qualified research professionals in licensed facilities. Users are responsible for ensuring compliance with all applicable laws regarding purchase and use of these materials.